SCHEMBL3570296

SCHEMBL3570296

C=CCC1(Nc2ccccc2)CCC(=O)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 4/20 0.35
GAA P10253 2/20 0.35
RECQL P46063 1/20 0.35
CYP1A2 P05177 2/20 0.34
ALDH1A1 P00352 2/20 0.33
POLB P06746 1/20 0.33
NPFFR1 Q9GZQ6 2/20 0.32
NPFFR2 Q9Y5X5 2/20 0.32
TGM2 P21980 1/20 0.32
KDM4E B2RXH2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
HTT P42858 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
HSP90AA1 P07900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6125581 0.87 NPFFR1 (0.35) CYP2C9MEN1KMT2ALMNAGAA
SCHEMBL9749001 0.79 NPFFR1 (0.46) CYP2C9MEN1KMT2ACYP1A2ALDH1A1
SCHEMBL3570132 0.79 ALDH1A1 (0.40) CYP2C9MEN1KMT2ALMNAGAA
SCHEMBL3563540 0.76 ALDH1A1 (0.40) MEN1KMT2ALMNAGAAALDH1A1
SCHEMBL3571850 0.74 MEN1 (0.39) CYP2C9MEN1KMT2AGAAALDH1A1
SCHEMBL17767879 0.74 NPFFR1 (0.60) CYP2C9MEN1KMT2AALDH1A1POLB
SCHEMBL3218332 0.68 HTT (0.36) CYP2C9MEN1KMT2ALMNAGAA
SCHEMBL31147778 0.66 MEN1 (0.31) CYP2C9MEN1KMT2A
SCHEMBL3561618 0.65 ALDH1A1 (0.43) MEN1KMT2ALMNAGAAALDH1A1
SCHEMBL11041464 0.63 MAPT (0.49) MEN1KMT2ALMNAGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121689-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-07-31 EP disclosed
US-8404740-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2013-03-26 US disclosed
US-20100048554-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US disclosed
EP-2121689-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2009-11-25 EP disclosed
WO-2008101659-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048554-A1 Spirocyclic Cyclohexane Compounds OPRL1, OPRD1, OPRK1 CYP2C9 1042/4885MEN1 3242/4885KMT2A 3999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.